Company
Bethesda
Every investor coverage indicates participated in a round Naval Medical Research Command (NMRC) Clinical Trials Center raised.
Companies Naval Medical Research Command (NMRC) Clinical Trials Center acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Naval Medical Research Command (NMRC) Clinical Trials Center. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Melbourne biotech ENA Respiratory has begun dosing participants in the second part of its Phase IIa trial of INNA-051; its investor lineup, past government funding awards and BLUE KNIGHT alumni status are recapped.
Melbourne biotech ENA Respiratory has begun dosing volunteers in a mid-stage trial of its INNA-051 antiviral spray, aimed at limiting common viral illnesses in at-risk groups.